Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the quick ratio (acid-test) high or low?
The quick ratio (acid-test) of 1.84 is in line with its 3-year average of 1.94, around the middle of its 3-year range (1.19–2.27).
As of the fiscal period ended Wednesday, December 31, 2025. 12.43% above its 12-month average of 1.63.
Reported quarterly quick ratio; no daily interpolation. Q2 FY2025 (2025-12-31): 1.84.
QUICK RATIO (ACID-TEST)
1.84
QUICK RATIO (ACID-TEST) AVG TTM
1.63
QUICK RATIO (ACID-TEST) AVG 3Y
N/A
QUICK RATIO (ACID-TEST) AVG 5Y
N/A
QUICK RATIO (ACID-TEST) AVG 10Y
N/A
QUICK RATIO (ACID-TEST) AVG 15Y
N/A
QUICK RATIO (ACID-TEST) AVG 20Y
N/A
CURRENT VS TTM AVG
+12.43%
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
2.83
median of 446 covered companies
CURRENT VS SECTOR MEDIAN
-35.00%
vs the sector median at left
Basel Medical Group Ltd Ordinary Shares
Market Cap
$4.96M
Quick Ratio (Acid-Test)
1.84
TTM Avg
1.63
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$4.99M
Quick Ratio (Acid-Test)
0.09
TTM Avg
0.18
3Y Avg
0.40
5Y Avg
0.95
Market Cap
$4.85M
Quick Ratio (Acid-Test)
5.58
TTM Avg
4.46
3Y Avg
3.04
5Y Avg
7.15
Market Cap
$4.79M
Quick Ratio (Acid-Test)
7.22
TTM Avg
2.13
3Y Avg
2.10
5Y Avg
5.04
Market Cap
$5.36M
Quick Ratio (Acid-Test)
3.01
TTM Avg
3.95
3Y Avg
2.52
5Y Avg
4.28
Market Cap
$4.46M
Quick Ratio (Acid-Test)
2.73
TTM Avg
3.29
3Y Avg
4.75
5Y Avg
4.47
Market Cap
$4.42M
Quick Ratio (Acid-Test)
1.35
TTM Avg
3.30
3Y Avg
6.18
5Y Avg
6.77
Market Cap
$4.41M
Quick Ratio (Acid-Test)
2.01
TTM Avg
0.91
3Y Avg
1.26
5Y Avg
1.78
| NAME | MARKET CAP | QUICK RATIO (ACID-TEST) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Basel Medical Group Ltd Ordinary Shares (BMGL) | $4.96M | 1.84 | 1.63 | N/A | N/A |
| Gelteq Limited Ordinary Shares (GELS)vs › | $4.99M | 0.09 | 0.18 | 0.40 | 0.95 |
| CalciMedica, Inc. (CALC)vs › | $4.85M | 5.58 | 4.46 | 3.04 | 7.15 |
| Bio Green Med Solution, Inc. (BGMS)vs › | $4.79M | 7.22 | 2.13 | 2.10 | 5.04 |
| Imunon, Inc. (IMNN)vs › | $5.21M | 1.82 | 1.99 | 2.53 | 3.43 |
| Alzamend Neuro Inc (ALZN)vs › | $5.36M | 3.01 | 3.95 | 2.52 | 4.28 |
| Dermata Therapeutics, Inc. (DRMA)vs › | $4.46M | 2.73 | 3.29 | 4.75 | 4.47 |
| CollPlant Biotechnologies Ltd. (CLGN)vs › | $4.42M | 1.35 | 3.30 | 6.18 | 6.77 |
| Ernexa Therapeutics Inc. (ERNA)vs › | $4.41M | 2.01 | 0.91 | 1.26 | 1.78 |
| Intelligent Bio Solutions Inc. (INBS)vs › | $5.54M | 1.35 | 1.00 | 0.98 | 1.86 |
Quick Ratio
1.84
Excludes inventory
Current Ratio
1.88
Includes inventory
Quick Ratio = (Current Assets − Inventory) / Current Liabilities
The quick ratio is a stricter liquidity measure that excludes inventory, showing the ability to meet short-term obligations with the most liquid assets.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | QUICK RATIO (ACID-TEST) |
|---|---|
| 2025-12-31 | 1.84 |
| 2025-06-30 | 1.19 |
| 2024-12-31 | 1.87 |
| 2024-06-30 | 2.25 |
| 2023-12-31 | 2.20 |
| 2023-06-30 | 2.27 |
